March 2014

Publications for March 2014

The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000–2008.

Scott A. Halperin

Pediatr Infect Dis J. , 2012; 31:956–963. doi:10.1097/INF.0b013e318260cc4d.

Influenza pandemics--pregnancy, pathogenesis, and perinatal outcomes.

Noni E. MacDonald

JAMA , 2012; 308(2):184-5.

The challenge of post-implementation surveillance for novel meningococcal vaccines.

Scott A. Halperin

Vaccine , 2012; 30 Suppl 2:B67–B72. doi: 10.1016/j.vaccine.2011.12.126

Healthy Child Uganda survey of knowledge, attitudes and behaviours of village health team members toward their health care responsibilities in southwest Uganda.

Noni E. MacDonald

Paediatr Child Health , 2012;17: e89

Continuous Monitoring of the Performance of Rubella IgG and Hepatitis B Surface Antibody Assays Using Reference Controls: Results of a Multicentre Trial 2012.

Todd F. Hatchette

Clin Vaccine Immunol , Aug 15

Cationic liposomes extend the immunostimulatory effect of CpG ODN against Burkholderia pseudomallei infection in BALB/c mice.

Robert Anderson and Yan Yan Huang

Clin Vaccine Immunol , 2012. 19, 675-683.

Development and validation of an HPLC/UV assay for separation and quantification of peptide antigens from a liposomal vaccine delivery platform.

Marc Mansour

J Pharm Biomed Anal. , 2012 Jul;66:176-82

Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Marina Ulanova

Clin Vaccine Immunol , 2012, 19:766-71.

Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals.

Scott A. Halperin

BMC Infectious Diseases , 2012; 12:306. doi: 10.1186/1471-2334-12-306.

Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22–23 November 2010

Joanne M. Langley

Vaccine , 2012 Mar 23;30(14):2399-404. Epub 2011 Dec 13.